Title
Category
Credits
Event date
Cost
- Investigator Initiated Trials
- 1.00 Participation
$0.00
Course DescriptionKaitlin Morrison, PhD takes you through the business principles of critical paths, PERT charts and Gantt charts and how they can be used to streamline clinical trial activation.
- Research to Practice
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Frances Collichio, MD, reviews the common and uncommon side effects of immune check point inhibitors. She also discusses the relatively new concept of delayed immune related events.
- Research to Practice
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Dominique Higgins, MD, PhD, provides an overview of diagnostic criteria for primary CNS brain tumors, and the current approved and investigational treatments that are available and on the horizon.
- Patient Centered Care
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 ODS
- 1.00 Participation
$0.00
Yara Abdou, MD, will delve into various aspects of early breast cancer, covering an overview of the epidemiological landscape of early-stage breast cancer, current screening guidelines, various subtypes of breast cancer and an overview of latest treatment strategies early breast cancer. The webinar will conclude with a focus on post-treatment surveillance and follow-up care for early breast cancer survivors.
- SAICEP
- 1.00 Participation
$0.00
Embracing Indigenous Wisdom in Evidence Based Cancer Prevention: A Path of Collaboration, Respect, and Insight on Duke’s Voyage” is a presentation that explores the partnership between modern scientific research and indigenous wisdom in the pursuit of effective cancer prevention strategies. It underscores the humility in learning from indigenous knowledge, and the discovery of insights that can enhance evidence-based approaches to cancer prevention.
- SAICEP
- 1.00 Participation
$0.00
Linda Burhansstipanov, MSPH, DRPH, OPN-CG provides an overview of how the field of patient navigation has evolved since its inception in the late 1980s / early 1990s. It includes a brief overview of the nationally recommended metrics and CMS codes for reimbursement of navigation services. It also identifies what is missing in the codes to fully address the cancer continuum.
- Research to Practice
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 ODS
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Christopher Dittus, DO, MPH, will provide an overview of how to diagnose Waldenstrom Macroglobulinemia (WM) and differentiate it from MGUS and other types of indolent lymphoma. he will discuss potential emergency situations related to hyperviscosity and how to effectively manage this complication. Regarding treatment, Dr. Dittus will discuss standard frontline and relapsed therapy and will review clinical trials evaluating immunotherapy and novel targeted agents.